|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,146.00 JPY | +1.18% |
|
-2.81% | +2.53% |
| 07-13 | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
| 07-10 | Health Care Down on Rotation Back to Tech - Health Care Roundup | DJ |
| Market Cap | 3,845B 23.74B 20.75B 19.18B 17.72B 33.37B 2,280B 33.97B 229B 89.73B 1,117B 89.17B 87.2B | P/E 2027 * |
11.2x | P/E 2028 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3,768B 23.26B 20.33B 18.79B 17.36B 32.7B 2,235B 33.29B 224B 87.94B 1,094B 87.39B 85.46B | EV / Sales 2027 * |
1.67x | EV / Sales 2028 * | 1.67x |
| Free-Float |
97.66% | Yield 2027 * |
3.75% | Yield 2028 * | 3.86% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +1.18% | ||
| 1 week | -2.81% | ||
| Current month | -1.33% | ||
| 1 month | +0.28% | ||
| 3 months | -16.19% | ||
| 6 months | -4.96% | ||
| Current year | +2.53% |
| 1 week | 2,109 |  | 2,200 |
| 1 month | 2,105 | | 2,216.5 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,422.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 09/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 31/10/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 09/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 31/05/2019 |
| Director/Board Member | 58 | 31/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.18% | -2.81% | +52.58% | +6.85% | 23.41B | |
| -2.19% | -6.34% | +44.78% | +157.48% | 1,054B | |
| -1.98% | -5.11% | +61.71% | +58.62% | 621B | |
| -1.00% | -3.70% | +28.04% | +80.30% | 438B | |
| -1.12% | -3.68% | +26.89% | +20.58% | 325B | |
| -1.73% | -3.45% | +26.95% | +44.09% | 281B | |
| -1.95% | -13.92% | +15.96% | +19.76% | 262B | |
| -1.45% | -2.37% | -27.87% | -39.87% | 219B | |
| -0.98% | -3.05% | +20.15% | +56.92% | 195B | |
| -0.37% | -4.10% | +16.67% | +69.41% | 163B | |
| Average | -1.21% | -1.92% | +26.59% | +47.41% | 357.96B | |
| Weighted average by Cap. | -1.68% | -1.70% | +33.53% | +76.99% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,255B 13.93B 12.17B 11.25B 10.39B 19.57B 1,338B 19.93B 134B 52.64B 655B 52.31B 51.15B | 2,072B 12.8B 11.18B 10.34B 9.55B 17.99B 1,229B 18.31B 123B 48.37B 602B 48.06B 47B |
| Net income | 343B 2.12B 1.85B 1.71B 1.58B 2.98B 203B 3.03B 20.41B 8.01B 99.64B 7.96B 7.78B | 327B 2.02B 1.77B 1.63B 1.51B 2.84B 194B 2.89B 19.46B 7.64B 95.02B 7.59B 7.42B |
| Net Debt | -76.78B -474M -414M -383M -354M -666M -45.54B -678M -4.57B -1.79B -22.3B -1.78B -1.74B | -391B -2.42B -2.11B -1.95B -1.8B -3.4B -232B -3.46B -23.27B -9.13B -114B -9.07B -8.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | JP¥2,146.00 | +1.18% | 5,802,100 |
| 13/07/26 | JP¥2,121.00 | -0.98% | 4,304,400 |
| 10/07/26 | JP¥2,142.00 | +0.21% | 5,971,100 |
| 09/07/26 | JP¥2,137.50 | -0.42% | 4,773,500 |
| 08/07/26 | JP¥2,146.50 | -1.29% | 6,198,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
